Juan A. Lopez

Cardiovascular Proteomics Laboratory And CIBER CV
Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Tissue mitochondrial activity dictates the macrophage pool size.

Tissue mitochondrial activity dictates the macrophage pool size.

Journal: Science immunology
Published: September 04, 2026

Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.

Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.

Journal: Haematologica
Published: March 10, 2026

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

Journal: Journal of the American Heart Association
Published: February 12, 2026

Erratum: Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Erratum: Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2025

Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2025

POMC AMPKα1 deletion drives male-specific BAT thermogenesis and obesity resistance.

POMC AMPKα1 deletion drives male-specific BAT thermogenesis and obesity resistance.

Journal: EMBO reports
Published: June 12, 2025

Arabidopsis INHIBITOR OF GROWTH 2 promotes flowering by regulating NuA4-dependent H4 acetylation levels at FT and SOC1.

Arabidopsis INHIBITOR OF GROWTH 2 promotes flowering by regulating NuA4-dependent H4 acetylation levels at FT and SOC1.

Journal: Plant physiology
Published: May 27, 2025

Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression.

Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression.

Journal: EMBO reports
Published: May 21, 2025

Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study.

Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study.

Journal: Cancers
Published: January 13, 2025

Exercise and tumor proteome: insights from a neuroblastoma model.

Exercise and tumor proteome: insights from a neuroblastoma model.

Journal: Physiological genomics
Published: September 23, 2024

ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.

ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.

Journal: International journal of molecular sciences
Published: August 30, 2024

Mechanically knocking out titin reveals protein tension loss as a trigger of muscle disease.

Mechanically knocking out titin reveals protein tension loss as a trigger of muscle disease.

Journal: Nature biomedical engineering
Published: August 29, 2024
Showing 1-12 of 107

Last Updated: 09/26/2026